SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-21-000008
Filing Date
2021-05-10
Accepted
2021-05-10 17:16:59
Documents
77
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20210331.htm   iXBRL 10-Q 1425931
2 EX-31.1 plrx-20210331xex311.htm EX-31.1 9716
3 EX-31.2 plrx-20210331xex312.htm EX-31.2 9684
4 EX-32.1 plrx-20210331xex321.htm EX-32.1 7369
  Complete submission text file 0001746473-21-000008.txt   6243782

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20210331.xsd EX-101.SCH 52500
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20210331_cal.xml EX-101.CAL 65148
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20210331_def.xml EX-101.DEF 303574
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20210331_lab.xml EX-101.LAB 587705
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20210331_pre.xml EX-101.PRE 408118
10 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20210331_htm.xml XML 814488
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 21908478
SIC: 2834 Pharmaceutical Preparations